prostaglandin
carboxylic acid
latanoprost free acid
0
390.24062
390.52
13,14-dihydro-17-phenyl-18,19,20-trinor-PGF2alpha
pubmed:22124989
ChEMBL:231987
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoic acid
pubmed:21788077
CiteXplore:21396362
pubmed:22136089
O=C(O)CCC/C=CC[C@@H]1[C@@H](CC[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O
CiteXplore:19289115
pubmed:19084521
Reaxys:5911495
Phxa 85
CiteXplore:22124989
pubmed:18451496
CiteXplore:20019365
CiteXplore:19084521
MESH:C109345
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoic acid
cas:41639-83-2
CHEBI:63925
HNPFPERDNWXAGS-NFVOFSAMSA-N
CiteXplore:22136089
pubmed:20019365
A prostaglandin F<small><sub>α</sub></small> that is an analogue of prostaglandin F<small><sub>2α</sub></small> in which the pentyl group has been replaced by 2-phenylethyl and where the the 13,14-double bond has undergone formal hydrogenation. Its isopropyl ester prodrug, latanoprost, is used in the treatment of open-angle glaucoma and ocular hypertension.
C23H34O5
CiteXplore:18451496
pubmed:21791206
latanoprost acid
InChI=1S/C23H34O5/c24-18(13-12-17-8-4-3-5-9-17)14-15-20-19(21(25)16-22(20)26)10-6-1-2-7-11-23(27)28/h1,3-6,8-9,18-22,24-26H,2,7,10-16H2,(H,27,28)/b6-1-/t18-,19+,20+,21-,22+/m0/s1
pubmed:19289115
CiteXplore:21791206
pubmed:21396362
ChemIDplus:41639-83-2
CiteXplore:21788077
chebi_ontology
reaxys:5911495
acid